Chronic Kidney Disease Should Not Prevent Women from Taking the Osteoporosis Drug Raloxifene (Newswise)
The osteoporosis drug raloxifene increases bone mineral density and reduces the risk of vertebral fractures among postmenopausal women with mild to moderate chronic kidney disease (CKD), according to a study appearing in the July 2008 issue of the Journal of the American Society Nephrology.